HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yu-Jing Zhang Selected Research
Yu-Jing Zhang Research Topics
Disease
30
Neoplasms (Cancer)
02/2022 - 02/2002
16
Lymphoma (Lymphomas)
01/2021 - 01/2015
12
Breast Neoplasms (Breast Cancer)
02/2022 - 04/2009
9
T-Cell Lymphoma (Lymphoma, T Cell)
01/2021 - 09/2015
9
Hepatocellular Carcinoma (Hepatoma)
11/2012 - 02/2002
4
Carcinogenesis
01/2011 - 04/2005
3
Extranodal NK-T-Cell Lymphoma
01/2021 - 01/2016
3
Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2015 - 04/2012
3
Rheumatoid Arthritis
10/2015 - 09/2013
2
Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2019
2
Ischemic Stroke
01/2017 - 01/2017
2
Fibrosis (Cirrhosis)
09/2016 - 01/2016
2
Autoimmune Diseases (Autoimmune Disease)
04/2014 - 09/2013
2
Infections
03/2010 - 03/2009
1
Triple Negative Breast Neoplasms
02/2022
1
Aortic Diseases
10/2021
1
Parkinson Disease (Parkinson's Disease)
01/2021
1
Mitral Valve Stenosis (Mitral Stenosis)
01/2021
1
Mitral Valve Insufficiency (Mitral Regurgitation)
01/2021
1
Atrial Fibrillation
01/2021
1
Ventilator-Associated Pneumonia
09/2020
1
Psoriasis (Pustulosis Palmaris et Plantaris)
07/2019
1
Pain (Aches)
12/2018
1
Hyperthermia
09/2018
1
Papillomavirus Infections
09/2018
1
Esophageal Squamous Cell Carcinoma
01/2018
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2017
1
Fistula
01/2017
1
Crohn Disease (Crohn's Disease)
01/2017
1
Stroke (Strokes)
01/2017
1
Liver Cirrhosis (Hepatic Cirrhosis)
01/2016
1
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
08/2015
1
HIV Seropositivity
04/2015
Drug/Important Bio-Agent (IBA)
7
DNA (Deoxyribonucleic Acid)
IBA
01/2019 - 04/2007
5
Pharmaceutical Preparations
IBA
01/2021 - 06/2010
5
Biomarkers (Surrogate Marker)
IBA
01/2019 - 04/2007
4
Anthracyclines
IBA
01/2021 - 12/2018
4
Asparaginase (Elspar)
FDA Link
12/2018 - 01/2016
4
Cytokines
IBA
09/2018 - 01/2013
4
Proteins (Proteins, Gene)
FDA Link
01/2017 - 02/2002
4
Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)
IBA
04/2010 - 05/2002
4
DNA Adducts
IBA
03/2009 - 05/2002
3
Biological Products
IBA
01/2021 - 06/2010
3
Aflatoxin B1 (Aflatoxin B)
IBA
05/2012 - 09/2006
2
Phenobarbital (Luminal)
FDA Link
02/2022 - 06/2016
2
human ERBB2 protein
IBA
01/2020 - 06/2016
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
09/2015 - 09/2015
2
Carcinogens
IBA
01/2011 - 03/2010
2
Aflatoxins
IBA
04/2005 - 02/2003
2
Environmental Carcinogens
IBA
02/2003 - 10/2002
1
Therapeutic Uses
IBA
01/2021
1
Selenium
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
Procalcitonin
IBA
09/2020
1
Progesterone Receptors (Progesterone Receptor)
IBA
01/2020
1
Estrogen Receptors
IBA
01/2020
1
Trastuzumab (Herceptin)
FDA Link
01/2020
1
Aurora Kinase A
IBA
07/2019
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
12/2018
1
pegaspargase (Oncaspar)
FDA Link
12/2018
1
Gemcitabine
FDA Link
12/2018
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
09/2018
1
NF-kappa B (NF-kB)
IBA
09/2018
1
Cisplatin (Platino)
FDA Link
Generic
01/2018
1
entinostat (MS 275)
IBA
01/2018
1
Polyphenols
IBA
01/2017
1
Lipopolysaccharides
IBA
01/2017
1
Glycyrrhizic Acid (Glycyrrhizin)
IBA
01/2017
1
HMGB1 Protein (HMG1)
IBA
01/2017
1
Paraffin
IBA
01/2017
1
Tea
IBA
01/2017
1
Ligands
IBA
10/2016
1
Thioacetamide (Thioacetamid)
IBA
09/2016
1
cucurbitacin E
IBA
09/2016
1
Resveratrol
IBA
01/2016
1
Resistin
IBA
10/2015
1
Rituximab (Mabthera)
FDA Link
08/2015
1
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
01/2015
1
Fluorouracil (Carac)
FDA Link
Generic
01/2015
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
01/2015
Therapy/Procedure
20
Radiotherapy
02/2022 - 07/2010
13
Drug Therapy (Chemotherapy)
01/2021 - 01/2015
6
Therapeutics
01/2020 - 06/2010
2
Modified Radical Mastectomy (Mastectomy, Modified)
02/2022 - 11/2020
2
Mastectomy (Mammectomy)
01/2020 - 04/2009
2
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
12/2018 - 09/2017
2
Transplantation
01/2017 - 06/2010
1
Stents
10/2021
1
Neoadjuvant Therapy
01/2021
1
Maze Procedure
01/2021
1
Immunotherapy
01/2021
1
Radiofrequency Ablation
01/2021
1
Segmental Mastectomy (Lumpectomy)
11/2020
1
Cupping Therapy
12/2018
1
Conformal Radiotherapy
09/2017
1
Treatment Delay
01/2017
1
Induction Chemotherapy
01/2016
1
Drug Tapering
01/2016
1
Condoms (Condom)
04/2015
1
Chemoradiotherapy
01/2015